subcutaneous injection of anti-myostatin peptides in CKD mice restored weight loss (5–7% increase) and muscle mass loss (~10% increase) in the hindlimbs, including the TA, gastrocnemius, EDL, and soleus muscles. This evidence concerns the gene MSTN and chronic kidney disease.